von Kobbe Cayetano, Harrigan Jeanine A, Schreiber Valérie, Stiegler Patrick, Piotrowski Jason, Dawut Lale, Bohr Vilhelm A
Laboratory of Molecular Gerontology, National Institute on Aging, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224, USA.
Nucleic Acids Res. 2004 Aug 3;32(13):4003-14. doi: 10.1093/nar/gkh721. Print 2004.
Werner syndrome (WS) is a genetic premature aging disorder in which patients appear much older than their chronological age. The gene mutated in WS encodes a nuclear protein (WRN) which possesses 3'-5' exonuclease and ATPase-dependent 3'-5' helicase activities. The genomic instability associated with WS cells and the biochemical characteristics of WRN suggest that WRN plays a role in DNA metabolic pathways such as transcription, replication, recombination and repair. Recently we have identified poly(ADP-ribose) polymerase-1 (PARP-1) as a new WRN interacting protein. In this paper, we further mapped the interacting domains. We found that PARP-1 bound to the N-terminus of WRN and to the C-terminus containing the RecQ-conserved (RQC) domain. WRN bound to the N-terminus of PARP-1 containing DNA binding and BRCA1 C-terminal (BRCT) domains. We show that unmodified PARP-1 inhibited both WRN exonuclease and helicase activities, and to our knowledge is the only known WRN protein partner that inactivates both of the WRN's catalytic activities suggesting a biologically significant regulation. Moreover, this dual inhibition seems to be specific for PARP-1, as PARP-2 did not affect WRN helicase activity and only slightly inhibited WRN exonuclease activity. The differential effect of PARP-1 and PARP-2 on WRN catalytic activity was not due to differences in affinity for WRN or the DNA substrate. Finally, we demonstrate that the inhibition of WRN by PARP-1 was influenced by the poly(ADP-ribosyl)ation state of PARP-1. The biological relevance of the specific modulation of WRN catalytic activities by PARP-1 are discussed in the context of pathways in which these proteins may function together, namely in the repair of DNA strand breaks.
沃纳综合征(WS)是一种遗传性早衰疾病,患者看起来比其实际年龄老得多。WS中发生突变的基因编码一种核蛋白(WRN),该蛋白具有3'-5'核酸外切酶和ATP酶依赖性3'-5'解旋酶活性。与WS细胞相关的基因组不稳定性以及WRN的生化特性表明,WRN在DNA代谢途径如转录、复制、重组和修复中发挥作用。最近,我们鉴定出聚(ADP-核糖)聚合酶-1(PARP-1)是一种新的与WRN相互作用的蛋白。在本文中,我们进一步绘制了相互作用结构域。我们发现PARP-1与WRN的N端以及包含RecQ保守(RQC)结构域的C端结合。WRN与包含DNA结合和BRCA1 C端(BRCT)结构域的PARP-1的N端结合。我们表明,未修饰的PARP-1抑制WRN核酸外切酶和解旋酶活性,据我们所知,它是唯一已知的使WRN的两种催化活性均失活的WRN蛋白伴侣,这表明存在生物学上显著的调节作用。此外,这种双重抑制似乎对PARP-1具有特异性,因为PARP-2不影响WRN解旋酶活性,仅轻微抑制WRN核酸外切酶活性。PARP-1和PARP-2对WRN催化活性的不同影响并非由于对WRN或DNA底物的亲和力差异。最后,我们证明PARP-1对WRN的抑制作用受PARP-1的聚(ADP-核糖基)化状态影响。在这些蛋白可能共同发挥作用的途径即DNA链断裂修复的背景下,讨论了PARP-1对WRN催化活性的特异性调节的生物学意义。